PTGS2 and glioma: COX-2 knockout also downregulated proteins involved in tumor–macrophage crosstalk, including CXCL2 and E-selectin, with CXCL2 being a pro-angiogenic chemokine linked to glioma progression and a potential therapeutic target [43,44,45].